Sudarshan Chemical Industries
SUDARSCHEM · NSE · Chemicals · India
Financials at a glance
Source: Yahoo FinanceAnnual
Quarterly · last 5
Revenue (FY2026)
₹9,787 Cr
Net margin
0.2%
Revenue CAGR (3y)
+62.0%
Profit CAGR (3y)
-20.7%
Net profit (FY2026)
₹22 Cr
Ask MarketChacha about SUDARSCHEM
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Why it moved
- Aug 5, 2026
Sudarshan Chemical Industries shares rose 3.56% with the broader market and sector amid no specific company news, results, or filings reported for August 5, 2026.
· confidence: low
Daily moves with the verified reason behind them. Education only — not investment advice.
Financials
Yearly
| Period | Revenue | Net profit | Net margin |
|---|---|---|---|
| FY2026 | ₹9,787 Cr | ₹22 Cr | 0.2% |
| FY2025 | ₹3,346 Cr | ₹60 Cr | 1.8% |
| FY2024 | ₹2,539 Cr | ₹357 Cr | 14.1% |
| FY2023 | ₹2,302 Cr | ₹45 Cr | 1.9% |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| Q1 FY27 | ₹2,642 Cr | ₹103 Cr | 12.30 | 3.9% |
| Q4 FY26 | ₹2,790 Cr | ₹83 Cr* | — | 3.0% |
| Q3 FY26 | ₹2,103 Cr | — | — | — |
| Q2 FY26 | ₹2,387 Cr | — | — | — |
| Q4 FY25 | ₹1,349 Cr | — | — | — |
* Net profit includes one-off / non-operating items (e.g. a settlement or accounting gain), so it doesn’t reflect operating performance — net margin is hidden for that period.
Figures as reported, in ₹ (crore). Source: Yahoo Finance.
Filings & announcements
2026
Announcement under Reg. 30 - Submission of revised investor presentation
BSE9/2/2026Submission of Investor Presentation
BSE9/1/2026Submission of Press Release under Regulation 30
BSE9/1/2026Diversification / Disinvestment
Intimation regarding execution of definitive Share Purchase and Transfer Agreement for sale of 100% stake in VP4 Frankfurt GmbH, a Step-Down Wholly-Owned Subsidiary of the Company
BSE9/1/2026Submission of Press Release under Regulation 30 of SEBI Listing Regulations, 2015
BSE8/25/2026Memorandum of Understanding /Agreements
Submission of intimation under Regulation 30(6) of SEBI Listing Regulations, 2015
BSE8/25/2026Submission of Transcript of Q1 FY27 Earnings Call
BSE8/20/2026Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 75th Annual General Meeting
BSE8/18/2026materialAnnouncement under Reg 30 - Acquisition
BSE8/12/2026materialSubmission Of Unaudited Financial Results For The Quarter Ended 30 June 2026
Submission of the Unaudited Financial Results for the quarter ended 30 June 2026
BSE8/12/2026Board Meeting Outcome for Outcome Of Board Meeting Held On 12 August 2026
Outcome of the Board Meeting held on 12 August 2026
BSE8/12/2026Business Responsibility and Sustainability Reporting (BRSR)
Submission of Business Responsibility and Sustainability Report for the Financial Year ended 31 March, 2026
BSE7/27/2026Submission Of The Notice Of 75Th Annual General Meeting
Submission of Notice of the 75th Annual General Meeting scheduled on Tuesday, 18th August, 2026
BSE7/27/2026materialSubmission of Annual Report including Business Responsibility Report for the Financial Year 2025-26 along with the Notice of 75th AGM of the Company scheduled on Tuesday, 18th August, 2026
BSE7/27/2026
In the news
- 4 Stocks to Watch as China+1 Reshapes India's Dye & Chemical IndustryEquitymaster · 9/1/2026
- Sudarshan Chemical: जर्मनीतील युनिट विकून कंपनीला मोठा निधी; जाणून घ्या डीलचे गणितWhalesbook · 9/1/2026
- Sudarshan Chemical sells VP4 stake to Celanese for EUR 76.5 millionscanx.trade · 8/31/2026
- Sudarshan Chemical Industries Ltd. Key Financial Ratios – Valuation, Profitability & MoreValue Research · 8/31/2026
- Clariant stock softens as Swiss additives plant sale reshapes portfolioAd-hoc-news.de · 8/25/2026
- Sudarshan Chemical Acquires Swiss Aluminium Dyes Plant for CHF 7 MillionWhalesbook · 8/25/2026
- Sudarshan Chemical inks pact to acquire manufacturing unit from Swiss company ClariantBusiness Standard · 8/25/2026
- Vijay Kedia Portfolio: 5 stocks surge up to 55% in CY26; 1 new addition in June quarterThe Economic Times · 8/22/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.